Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Andrea Viale
Affiliation
The University of Texas MD Anderson Cancer Center
ORCID
Career Start Year
2001
Papers
45
H Index
23
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36865225
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma.
bioRxiv
2023
37790498
KRAS inhibition activates an actionable CD24 'don't eat me' signal in pancreas cancer.
bioRxiv
2023
37786705
Evolutionary fingerprints of EMT in pancreatic cancers.
bioRxiv
2023
37186844
SMARCB1 regulates the hypoxic stress response in sickle cell trait.
Proc Natl Acad Sci U S A
2023
37069167
Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis.
Nat Commun
2023
36411320
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells.
Nat Cancer
2022
35697807
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.
Nat Biotechnol
2022
33158812
Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.
Cancer Res
2021
33745946
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer.
Gastroenterology
2021
34529467
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.
Science
2021
34039636
Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma.
Cancer Discov
2021
34062049
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.
EMBO Mol Med
2021
34330913
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.
Nat Commun
2021
32977289
Leukotrienes, a potential target for Covid-19.
Prostaglandins Leukot Essent Fatty Acids
2020
30753823
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.
Cancer Cell
2019
31623133
The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?
Cancers (Basel)
2019
30918400
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.
Nature
2019
30726735
Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors.
Cell Rep
2019
30602939
Analytical mechanics of asteroid disassembly using the Orbital Siphon effect.
Proc Math Phys Eng Sci
2018
28178232
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.
Nature
2017
28099419
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer.
Nature
2017
26799652
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Autophagy
2016
27557537
Metabolic Features of Cancer Treatment Resistance.
Recent Results Cancer Res
2016
27320920
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.
Cell Rep
2016
25736685
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer.
Cancer Res
2015
26374463
Tumors and mitochondrial respiration: a neglected connection.
Cancer Res
2015
26445511
Sugar? No Thank You, Just a Deep Breath of Oxygen for Cancer Stem Cells.
Cell Metab
2015
25965571
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.
Cancer Cell
2015
24954535
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.
Cell
2014
25227008
Quest for an open MRI scanner.
Biomed Mater Eng
2014
25119024
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
Nature
2014
23584564
NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model.
Leukemia
2013
24091730
A non-redundant function of cyclin E1 in hematopoietic stem cells.
Cell Cycle
2013
23417300
DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions.
Proc Natl Acad Sci U S A
2013
22541435
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.
Cell
2012
23226099
Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential.
Neoplasia
2012
21331069
The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha.
Leukemia
2011
19122635
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells.
Nature
2009
20049708
Awaking stem cells from dormancy: growing old and fighting cancer.
EMBO Mol Med
2009
19713969
Does treatment with olmesartan improve arterial stenoses due to fibromuscular dysplasia?
Hypertens Res
2009
16418776
Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease.
J Bone Miner Res
2006
15619634
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway.
Nat Med
2005
15208264
Vasculogenic potential of long term repopulating cord blood progenitors.
FASEB J
2004
12453876
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.
Blood
2002
11313686
Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reaction.
Bone Marrow Transplant
2001
1 - 45 of 45
Column Actions
Search
Recommended Authors
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year
2013
Number of shared co-authors
0
Tuo Zhang
Weill Cornell Medical College.
Career Start Year
2013
Number of shared co-authors
3
Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year
2012
Number of shared co-authors
13
Evangelos Pazarentzos
University of California san francisco
Career Start Year
2011
Number of shared co-authors
0
Faiyaz Notta
2Ontario Institute for Cancer Research
Career Start Year
2009
Number of shared co-authors
2
Krushna C Patra
Harvard Medical School
Career Start Year
2009
Number of shared co-authors
0
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year
2008
Number of shared co-authors
6
Louis Vermeulen
Oncode Institute
Career Start Year
2006
Number of shared co-authors
4
Gina M DeNicola
H. Lee. Moffitt Cancer Center
Career Start Year
2005
Number of shared co-authors
4
Kris C Wood
Duke University
Career Start Year
2005
Number of shared co-authors
5
Nicholas A Graham
University of Southern California
Career Start Year
2004
Number of shared co-authors
1
Donghui Cheng
University of California los angeles
Career Start Year
2003
Number of shared co-authors
1
Kristopher K Frese
Cancer Research UK Manchester Institute, University of Manchester
Career Start Year
2003
Number of shared co-authors
1
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year
2003
Number of shared co-authors
11
Eric A Collisson
University of California san francisco
Career Start Year
1999
Number of shared co-authors
5
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1998
Number of shared co-authors
1
Hal K Berman
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1997
Number of shared co-authors
2
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year
1996
Number of shared co-authors
1
Nabeel Bardeesy
Massachusetts General Hospital
Career Start Year
1992
Number of shared co-authors
10
James DeGregori
University of Colorado Anschutz Medical Campus
Career Start Year
1991
Number of shared co-authors
1
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year
1989
Number of shared co-authors
0
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Career Start Year
1989
Number of shared co-authors
2
Emile E Voest
The Netherlands Cancer Institute
Career Start Year
1989
Number of shared co-authors
4
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year
1987
Number of shared co-authors
2
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year
1987
Number of shared co-authors
12
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year
1987
Number of shared co-authors
1
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year
1979
Number of shared co-authors
5
Chi V Dang
Johns Hopkins University School of Medicine
Career Start Year
1978
Number of shared co-authors
6
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1975
Number of shared co-authors
2
Norman E Sharpless
National Cancer Institute
Career Start Year
1945
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Timothy P Heffernan
Co-authored papers
15
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers
10
Sahil Seth
The University of Texas MD Anderson Cancer Center
Co-authored papers
8
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers
6
Luigi Nezi
Istituto Europeo di Oncologia IRCCS
Co-authored papers
6
Costas A Lyssiotis
Co-authored papers
5
Lynda Chin
Co-authored papers
5
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Co-authored papers
5
Avnish Kapoor
Co-authored papers
4
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Co-authored papers
3
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
Baoli Hu
Co-authored papers
3
Sujun Hua
Co-authored papers
3
Charles W M Roberts
Co-authored papers
2
Charles Swanton
Francis Crick Institute
Co-authored papers
2
Nikolai Engedal
Institute for Cancer Research, Oslo University Hospital
Co-authored papers
2
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers
2
Adrian L Harris
University of Oxford
Co-authored papers
2
Yonathan Lissanu Deribe
Co-authored papers
2
Lewis C Cantley
Co-authored papers
2
Liren Li
Co-authored papers
2
Guillermo Garcia-Manero
MD Anderson Cancer Center
Co-authored papers
2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers
2
Joseph R Daniele
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Ian G Mills
Queen's University Belfast
Co-authored papers
1
Ernst J Wolvetang
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers
1
Terence P Speed
Walter and Eliza Hall Institute of Medical Research
Co-authored papers
1
Manish K Aghi
University of California san francisco
Co-authored papers
1
1 - 30